Filter Results:
(4,674)
Show Results For
- All HBS Web
(4,674)
- People (16)
- News (1,856)
- Research (2,242)
- Events (2)
- Multimedia (213)
- Faculty Publications (1,821)
Show Results For
- All HBS Web
(4,674)
- People (16)
- News (1,856)
- Research (2,242)
- Events (2)
- Multimedia (213)
- Faculty Publications (1,821)
- October 2021 (Revised February 2022)
- Case
Hospital 57357: Aligning Performance Towards a Vision of a Cancer-Free Childhood
By: Susanna Gallani and Youssef Abdel Aal
The case follows the Children Cancer Hospital in Egypt, also known as Hospital 57357, as it goes through the roll-out of a new performance management system, which Dr. Sherif Abouel Naga, founder and CEO of the hospital, had championed. This was a critical juncture as... View Details
Keywords: Healthcare; Performance Management; Performance Incentives; Strategic Alignment; Health Care and Treatment; Nonprofit Organizations; Strategy; Alignment; Performance Evaluation; Mission and Purpose; Change Management; Health Industry; Egypt; Middle East
Gallani, Susanna, and Youssef Abdel Aal. "Hospital 57357: Aligning Performance Towards a Vision of a Cancer-Free Childhood." Harvard Business School Case 122-041, October 2021. (Revised February 2022.)
- June 2008 (Revised November 2010)
- Supplement
Patient Flow at Brigham and Women's Hospital (B)
By: Anita L. Tucker and Jillian Alexandra Berry
The B Case is an email from the ED Director. He clarifies where the process deviations occurred. View Details
Keywords: Change Management; Health Care and Treatment; Service Operations; Business Processes; Performance Productivity; Conflict and Resolution; Health Industry; Massachusetts
Tucker, Anita L., and Jillian Alexandra Berry. "Patient Flow at Brigham and Women's Hospital (B)." Harvard Business School Supplement 608-172, June 2008. (Revised November 2010.)
- April 1989 (Revised May 1993)
- Case
Novel Combination of Two Drugs (A)
Herzlinger, Regina E. "Novel Combination of Two Drugs (A)." Harvard Business School Case 189-168, April 1989. (Revised May 1993.)
- 13 Dec 2016
- First Look
December 13, 2016
fundamental firm value, which is gradually revealed into prices. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=51971 December 2016 Harvard Business Review Health Care Needs Real... View Details
Keywords: Carmen Nobel
- 19 Jan 2022
- In Practice
7 Trends to Watch in 2022
As 2022 gets underway we asked our faculty to highlight some trends worth watching in the coming year. Ariel Stern: A new future for digital health care While 2020 and 2021 were years of rapid innovation and deployment of new health care technologies and delivery... View Details
Keywords: by HBS News
- 2009
- Working Paper
Input Constraints and the Efficiency of Entry: Lessons from Cardiac Surgery
By: David M. Cutler, Robert S. Huckman and Jonathan T. Kolstad
Prior studies suggest that, with elastically supplied inputs, free entry may lead to an inefficiently high number of firms in equilibrium. Under input scarcity, however, the welfare loss from free entry is reduced. Further, free entry may increase use of high-quality... View Details
- 01 Mar 2011
- News
Fixing What Ails the Drug Industry
In 2008, private investors and the National Institutes of Health plowed more than $100 billion into pharmaceutical research. And yet, “We’re not seeing the new diagnostics, treatments, preventative approaches, and cures that we might have... View Details
- October 2024
- Case
Allurion: Competing in the Age of GLP-1
By: Satish Tadikonda, Rajiv Lal, David Lane and Sarah Sasso
Shantanu Gaur had built Allurion into a formidable business internationally, providing obesity patients with a less invasive option long before GLP-1 drugs became the latest craze. Selling Allurion's medical device across 60+ countries, he awaited FDA approval to bring... View Details
- November 2012
- Supplement
Amylin Pharmaceuticals (B)
By: Richard G. Hamermesh and Carin-Isabel Knoop
Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the company remained unprofitable as sales plateaued. The small pharmaceutical... View Details
Keywords: Pharmaceuticals; Bristol-Myers Squibb; Health Care and Treatment; Pharmaceutical Industry; United States
Hamermesh, Richard G., and Carin-Isabel Knoop. "Amylin Pharmaceuticals (B)." Harvard Business School Supplement 813-091, November 2012.
- Simulation
Going to the Dentist: Futuredontics
By: Gerald Zaltman
Keywords: Health Care and Treatment
- 01 Mar 2008
- News
India's Chidambaram Says Nation Is "Poor Rich"
reforms. Education and health care are the country’s two most formidable challenges, Chidambaram observed. Stating that India must become “a knowledge society,” he noted that while the country is known for... View Details
- 01 Dec 2003
- News
HIV/AIDS and Business
incorporates human rights, development, and health issues — it’s the ultimate strategic challenge.” At the Kennedy School workshop, participants discussed a case coauthored by Barrett and Ballou-Aares on Heineken’s efforts to implement an... View Details
- January 2010
- Teaching Note
The Joslin Diabetes Center (TN)
By: Michael E. Porter, Elizabeth O. Teisberg and Scott Wallace
Teaching Note for [710424]. View Details
- July 2002 (Revised August 2002)
- Case
Washington Hospital Center (A): Rescuing Emergency Medicine
By: Rosabeth M. Kanter and Michelle Heskett
Dr. Craig Feied and Dr. Mark Smith, recruited to turn around the Washington Hospital Center Emergency Department, prepare to roll out their most revolutionary change yet--an information system that could radically improve the practice of emergency medicine. A review of... View Details
- 12 Jul 2015
- News
How Genzyme became a source of biotech executives
- 08 Apr 2015
- News
3 key skills clinicians need in executive roles
- 18 Sep 2014
- News
The shortcomings of the corporate wellness program
- 05 Oct 2007
- News
Aspen Institute Project Targets Broader Healthcare Stewardship
- 01 Oct 2006
- News